abstract |
The invention discloses a quinazoline compound, its intermediate, preparation method, pharmaceutical composition and application. The quinazoline compound of the present invention has a good inhibitory effect on protein kinase JAK, and can be used to prepare medicines for preventing, treating or adjuvantly treating various diseases related to the expression or activity of JAK, especially tumor diseases and immune diseases. |